Last 12 months
Inside the activity.
6 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 4 | 5 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 14, 2026 Filed Jul 15, 2026 19:36 UTC |
HRT FINANCIAL LP10% owner
|
SaleCommon Stock | 82,116 | $4.48 | $367,879.68 |
DisclosureSEC source: 0001475597-26-000159 · primary_doc.xml · nonDerivative · entry 2 HRT FINANCIAL LP · CIK 0001475597 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| July 13, 2026 Filed Jul 15, 2026 19:36 UTC |
HRT FINANCIAL LP10% owner
|
SaleCommon Stock | 1,033 | $4.67 | $4,824.11 |
DisclosureSEC source: 0001475597-26-000159 · primary_doc.xml · nonDerivative · entry 1 HRT FINANCIAL LP · CIK 0001475597 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,238 Read SEC document |
| July 10, 2026 Filed Jul 13, 2026 18:34 UTC |
HRT FINANCIAL LP10% owner
|
PurchaseCommon Stock | 731 | $3.11 | $2,273.41 |
DisclosureSEC source: 0001475597-26-000154 · primary_doc.xml · nonDerivative · entry 2 HRT FINANCIAL LP · CIK 0001475597 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,271 Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 18:34 UTC |
HRT FINANCIAL LP10% owner
|
PurchaseCommon Stock | 8,266 | $3.38 | $27,939.08 |
DisclosureSEC source: 0001475597-26-000154 · primary_doc.xml · nonDerivative · entry 1 HRT FINANCIAL LP · CIK 0001475597 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,540 Read SEC document |
| July 08, 2026 Filed Jul 9, 2026 21:50 UTC |
HRT FINANCIAL LP10% owner
|
SaleCommon Stock | 18,531 | $3.52 | $65,229.12 |
DisclosureSEC source: 0001475597-26-000144 · primary_doc.xml · nonDerivative · entry 2 HRT FINANCIAL LP · CIK 0001475597 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,274 Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 21:50 UTC |
HRT FINANCIAL LP10% owner
|
SaleCommon Stock | 10,580 | $3.33 | $35,231.40 |
DisclosureSEC source: 0001475597-26-000144 · primary_doc.xml · nonDerivative · entry 1 HRT FINANCIAL LP · CIK 0001475597 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,805 Read SEC document |
| July 06, 2026 Filed Jul 7, 2026 20:23 UTC |
HRT FINANCIAL LP10% owner
|
SaleCommon Stock | 9,022 | $3.51 | $31,667.22 |
DisclosureSEC source: 0001475597-26-000138 · primary_doc.xml · nonDerivative · entry 2 HRT FINANCIAL LP · CIK 0001475597 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,385 Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:23 UTC |
HRT FINANCIAL LP10% owner
|
PurchaseCommon Stock | 7,851 | $3.54 | $27,792.54 |
DisclosureSEC source: 0001475597-26-000138 · primary_doc.xml · nonDerivative · entry 1 HRT FINANCIAL LP · CIK 0001475597 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,407 Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 17:37 UTC |
HRT FINANCIAL LP10% owner
|
PurchaseCommon Stock | 3,959 | $3.30 | $13,064.70 |
DisclosureSEC source: 0001475597-26-000128 · primary_doc.xml · nonDerivative · entry 1 HRT FINANCIAL LP · CIK 0001475597 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,556 Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:17 UTC |
HRT FINANCIAL LP10% owner
|
PurchaseCommon Stock | 6,755 | $3.23 | $21,818.65 |
DisclosureSEC source: 0001475597-26-000123 · primary_doc.xml · nonDerivative · entry 2 HRT FINANCIAL LP · CIK 0001475597 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,597 Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:17 UTC |
HRT FINANCIAL LP10% owner
|
PurchaseCommon Stock | 25,836 | $3.44 | $88,875.84 |
DisclosureSEC source: 0001475597-26-000123 · primary_doc.xml · nonDerivative · entry 1 HRT FINANCIAL LP · CIK 0001475597 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,842 Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 21:22 UTC |
Lorber Timothy J.Chief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 24,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-023275 · ownership.xml · derivative · entry 2 Lorber Timothy J. · CIK 0002027850 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,854 Underlying: Common Stock · 24,854 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F3 · derivative.exercise_date: These RSUs will vest on 02/08/2026. F3 · derivative.expiration_date: These RSUs will vest on 02/08/2026. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 21:22 UTC |
Lorber Timothy J.Chief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 29,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-023275 · ownership.xml · derivative · entry 1 Lorber Timothy J. · CIK 0002027850 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,240 Underlying: Common Stock · 29,240 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. F2 · derivative.expiration_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. Read SEC document |
| August 08, 2025 Filed Aug 13, 2025 01:48 UTC |
Nabyt OlehDirector
|
GrantRestricted Stock Unit · Derivative | 29,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-023279 · ownership.xml · derivative · entry 1 Nabyt Oleh · CIK 0002060299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,240 Underlying: Common Stock · 29,240 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. F2 · derivative.expiration_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. Read SEC document |
| August 08, 2025 Filed Aug 13, 2025 01:24 UTC |
Scorsis GeorgeDirector
|
GrantRestricted Stock Unit · Derivative | 29,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-023277 · ownership.xml · derivative · entry 1 Scorsis George · CIK 0002060026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,240 Underlying: Common Stock · 29,240 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. F2 · derivative.expiration_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. Read SEC document |
| August 08, 2025 Filed Aug 13, 2025 01:23 UTC |
Tung JosephDirector
|
GrantRestricted Stock Unit · Derivative | 29,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-023276 · ownership.xml · derivative · entry 1 Tung Joseph · CIK 0002060609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,240 Underlying: Common Stock · 29,240 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. F2 · derivative.expiration_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. Read SEC document |
| August 08, 2025 Filed Aug 13, 2025 12:33 UTC |
Richards Steven MDirector
|
GrantRestricted Stock Unit · Derivative | 29,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-023376 · ownership.xml · derivative · entry 1 Richards Steven M · CIK 0001945980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,240 Underlying: Common Stock · 29,240 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. F2 · derivative.exercise_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. F2 · derivative.expiration_date: One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028. Read SEC document |
| December 31, 2024 Filed Feb 3, 2025 19:30 UTC |
Richards Steven MDirector
|
GrantCommon Stock | 209,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-004732 · ownership.xml · nonDerivative · entry 1 Richards Steven M · CIK 0001945980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,004 F1 · shares: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027. F2 · balance_after: Consists of (1) 214 shares of common stock and (2) 209,790 RSUs which remain subject to vesting. Read SEC document |
| December 31, 2024 Filed Feb 4, 2025 00:30 UTC |
Schafer JoshuaDirector
|
GrantCommon Stock | 209,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-004733 · ownership.xml · nonDerivative · entry 1 Schafer Joshua · CIK 0001945557 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,004 F1 · shares: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs which are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027. F2 · balance_after: Consists of (1) 214 shares of common stock and (2) 209,790 RSUs which remain subject to vesting. Read SEC document |
| December 23, 2024 Filed Feb 5, 2025 16:55 UTC |
Brown MiltonDirector
|
GrantCommon Stock | 209,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-005035 · ownership.xml · nonDerivative · entry 1 Brown Milton · CIK 0001945206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,617 F1 · shares: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs which are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027. F2 · balance_after: Consists of (1) 135,785 shares of common stock and (2) 210,832 RSUs, which remain subject to vesting. Read SEC document |
| December 23, 2024 Filed Feb 6, 2025 19:33 UTC Amendment |
Richards Steven MDirector
|
GrantCommon Stock | 209,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-005265 · ownership.xml · nonDerivative · entry 1 Richards Steven M · CIK 0001945980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,004 F1 · shares: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027. F2 · balance_after: Consists of (1) 214 shares of common stock and (2) 209,790 RSUs which remain subject to vesting. Read SEC document |
| December 23, 2024 Filed Feb 7, 2025 00:34 UTC Amendment |
Schafer JoshuaDirector
|
GrantCommon Stock | 209,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-005267 · ownership.xml · nonDerivative · entry 1 Schafer Joshua · CIK 0001945557 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,004 F1 · shares: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs which are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027. F2 · balance_after: Consists of (1) 214 shares of common stock and (2) 209,790 RSUs which remain subject to vesting. Read SEC document |
| May 01, 2024 Filed Oct 9, 2024 17:00 UTC |
Jung MiraChief Scientific Officer
|
GrantCLASS A COMMON STOCK | 598 | $11.28 | $6,745.44 |
DisclosureSEC source: 0001493152-24-040614 · ownership.xml · nonDerivative · entry 1 Jung Mira · CIK 0001945307 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,715 F1 · shares: The Reporting Person received a grant of 1,791 restricted stock units ("RSUs") on May 1, 2023 (14,326 RSUs on a pre-reverse split basis), which RSUs are subject to vesting over a period of three years. The first vesting of 598 RSUs occurred on May 1, 2024. F2 · balance_after: Consists of (i) 134,522 shares of common stock and (ii) 1,193 RSUs which remain subject to vesting. All share and RSU numbers reflect a 1-for-8 reverse stock split effected by the issuer on August 13, 2024. Read SEC document |
| March 08, 2024 Filed Mar 8, 2024 18:18 UTC |
Vander Hoek MichaelChief Financial Officer
|
GrantCOMMON STOCK | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-009451 · ownership.xml · nonDerivative · entry 1 Vander Hoek Michael · CIK 0001945351 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,852 Read SEC document |
| December 13, 2023 Filed Dec 21, 2023 02:51 UTC |
Jacobs BetteDirector
|
SaleCommon Stock | 4,157 | $0.46 | $1,925.52 |
DisclosureSEC source: 0001493152-23-045648 · ownership.xml · nonDerivative · entry 1 Jacobs Bette · CIK 0001953668 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,064 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of (i) 15,201 shares of common stock and (ii) 11,863 RSUs which remain subject to certain vesting conditions. Read SEC document |
| December 13, 2023 Filed Jan 2, 2024 17:10 UTC |
Brown MiltonDirector
|
SaleCommon Stock | 2,921 | $0.46 | $1,353.01 |
DisclosureSEC source: 0001493152-24-000125 · ownership.xml · nonDerivative · entry 1 Brown Milton · CIK 0001945206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,094,610 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of (i) 1,077,943 shares of common stock and (ii) 16,667 RSUs which remain subject to certain vesting conditions. Read SEC document |
| August 14, 2023 Filed Aug 18, 2023 23:48 UTC |
Dritschilo AnatolyDirector · CEO and Chairman · 10% owner
|
GiftCOMMON STOCK | 2,100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-029472 · ownership.xml · nonDerivative · entry 2 Dritschilo Anatoly · CIK 0001945126 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By PAL Trust Disclosed balance after: 2,100,000 F3 · balance_after: Consists of 2,100,000 shares gifted by the Reporting Person's spouse to PAL Trust, a trust formed for the benefit of the Reporting Person's adult children and for which a third party serves as external trustee and two of the Reporting Person's children serve as co-trustees. Beneficial ownership is disclaimed except to the extent the Reporting Person's spouse maintains any pecuniary interest therein. The inclusion in this report of the 2,100,000 shares held by the trust for the benefit of the Reporting Person's adult children shall in no way be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 14, 2023 Filed Aug 18, 2023 23:48 UTC |
Dritschilo AnatolyDirector · CEO and Chairman · 10% owner
|
GiftCOMMON STOCK | 2,100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-029472 · ownership.xml · nonDerivative · entry 1 Dritschilo Anatoly · CIK 0001945126 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 1,104,407 F1 · shares: Represents 2,100,000 shares held by the spouse of the Reporting Person, and over which the Reporting Person disclaims any beneficial ownership or control. Prior to the contribution, the Reporting Person's spouse held a total of 3,204,407 shares. On August 14, 2023, she contributed 2,100,000 shares to PAL Trust, a trust formed for the benefit of her adult children. F2 · balance_after: Consists of 1,104,407 shares held by the spouse of the Reporting Person. The inclusion in this report of the 1,104,407 shares held by the Reporting Person's spouse shall in no way be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 08:29 UTC |
Brown MiltonDirector
|
GrantStock Options · Derivative | 25,000 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001493152-23-005375 · ownership.xml · derivative · entry 1 Brown Milton · CIK 0001945206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2028-02-15 F1 · balance_after: The Reporting Person received 25,000 stock options ("Stock Options") to purchase shares of SHPH common stock on February 15, 2023, which Stock Options vest in full on the first anniversary of the date of grant. Read SEC document |
| December 29, 2022 Filed Dec 30, 2022 16:06 UTC |
Vander Hoek MichaelChief Financial Officer
|
SaleCOMMON STOCK | 2,243 | $1.61 | $3,600.02 |
DisclosureSEC source: 0001493152-22-037141 · ownership.xml · nonDerivative · entry 1 Vander Hoek Michael · CIK 0001945351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,852 F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6,095 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of 3,852 shares of SHPH common stock. Read SEC document |
| December 29, 2022 Filed Dec 30, 2022 20:48 UTC |
Dritschilo PeterPresident and COO
|
SaleCOMMON STOCK | 3,820 | $1.61 | $6,131.10 |
DisclosureSEC source: 0001493152-22-037210 · ownership.xml · nonDerivative · entry 1 Dritschilo Peter · CIK 0001944900 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,560 F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 10,380 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of 6,560 shares of SHPH common stock. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 06:10 UTC |
Rich TyvinChief Medical Officer
|
SaleCOMMON STOCK | 1,414 | $1.61 | $2,269.47 |
DisclosureSEC source: 0001493152-23-000014 · ownership.xml · nonDerivative · entry 1 Rich Tyvin · CIK 0001945208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,429 F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 3,843 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of 2,429 shares of SHPH common stock. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 06:10 UTC |
Jung MiraChief Scientific Officer
|
SaleCLASS A COMMON STOCK | 328 | $1.61 | $526.44 |
DisclosureSEC source: 0001493152-23-000013 · ownership.xml · nonDerivative · entry 1 Jung Mira · CIK 0001945307 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,071,388 F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 892 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of 1,071,388 shares of SHPH common stock. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 11:20 UTC |
Dritschilo AnatolyDirector · CEO and Chairman · 10% owner
|
SaleCOMMON STOCK | 8,372 | $1.61 | $13,437.06 |
DisclosureSEC source: 0001493152-23-000026 · ownership.xml · nonDerivative · entry 1 Dritschilo Anatoly · CIK 0001945126 · Director · CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085,200 F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 22,748 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of 1,085,200 shares of common stock held directly by the Reporting Person. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 11:10 UTC |
Jacobs BetteDirector
|
SaleCLASS A COMMON STOCK | 4,366 | $1.61 | $7,007.43 |
DisclosureSEC source: 0001493152-23-000012 · ownership.xml · nonDerivative · entry 1 Jacobs Bette · CIK 0001953668 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,221 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 11,862 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of 7,496 shares of SHPH common stock and 23,725 RSUs, with each RSU representing the right to receive one share of SHPH common stock upon vesting, which RSUs remain subject to certain vesting conditions. Read SEC document |
| December 29, 2022 Filed Jan 4, 2023 16:10 UTC |
Brown MiltonDirector
|
SaleCOMMON STOCK | 995 | $1.61 | $1,596.98 |
DisclosureSEC source: 0001493152-23-000318 · ownership.xml · nonDerivative · entry 1 Brown Milton · CIK 0001945206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,531 F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of 1,072,531 shares of SHPH common stock. Read SEC document |
| December 29, 2022 Filed Jan 4, 2023 21:10 UTC |
Adkins WilliamFormer Director
|
SaleCOMMON STOCK | 995 | $1.61 | $1,596.98 |
DisclosureSEC source: 0001493152-23-000319 · ownership.xml · nonDerivative · entry 1 Adkins William · CIK 0001945434 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,071 F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of (i) 1,707 shares of Common Stock held by the Reporting Person and (ii) 182,364 shares of common stock held by the William Henry Adkins and Pauline Adkins 1993 Revocable Trust (the "Adkins Trust"). Read SEC document |
| December 29, 2022 Filed Jan 9, 2023 16:10 UTC |
Richards Steven MDirector
|
SaleCOMMON STOCK | 995 | $1.61 | $1,596.98 |
DisclosureSEC source: 0001493152-23-000941 · ownership.xml · nonDerivative · entry 1 Richards Steven M · CIK 0001945980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,707 F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of 1,707 shares of SHPH common stock. Read SEC document |
| December 29, 2022 Filed Mar 14, 2024 21:02 UTC |
Senanayake ChrisDirector
|
SaleCOMMON STOCK | 1,626 | $1.61 | $2,609.73 |
DisclosureSEC source: 0001493152-24-009980 · ownership.xml · nonDerivative · entry 1 Senanayake Chris · CIK 0001945766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,791 F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 4,417 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of 2,791 shares of SHPH common stock. Read SEC document |
| September 02, 2022 Filed Jan 4, 2023 21:10 UTC |
Adkins WilliamFormer Director
|
OtherWARRANTS (right to buy) · Derivative | 138,889 | Not disclosed Strike: $4.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-000319 · ownership.xml · derivative · entry 2 Adkins William · CIK 0001945434 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,889 Underlying: Common Stock · 138,889 shares Expires 2025-09-02 F3 · security: Consists of warrants to purchase 138,889 shares of common stock held by the Adkins Trust. The Adkins Trust was a holder of the Issuer's Series A convertible preferred stock, which stock converted into commons stock upon completion of the Issuer's IPO and at which time the warrants were issued to the Series A holders in accordance with the terms of the Series A preferred stock offering. F3 · kind: Consists of warrants to purchase 138,889 shares of common stock held by the Adkins Trust. The Adkins Trust was a holder of the Issuer's Series A convertible preferred stock, which stock converted into commons stock upon completion of the Issuer's IPO and at which time the warrants were issued to the Series A holders in accordance with the terms of the Series A preferred stock offering. F3 · price: Consists of warrants to purchase 138,889 shares of common stock held by the Adkins Trust. The Adkins Trust was a holder of the Issuer's Series A convertible preferred stock, which stock converted into commons stock upon completion of the Issuer's IPO and at which time the warrants were issued to the Series A holders in accordance with the terms of the Series A preferred stock offering. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.